Currently out of the existing stock ratings of Michael Tupholme, 12 are a BUY (80%), 3 are a HOLD (20%).

Michael Tupholme

Work Performance Price Targets & Ratings Chart

Analyst Michael Tupholme, currently employed at TD COWEN, carries an average stock price target met ratio of 65% that have a potential upside of 48.08% achieved within 577 days.

Michael Tupholme’s has documented 30 price targets and ratings displayed on 2 stocks. The coverage is on the Basic Materials sector.

Most recent stock forecast was given on NTR, Nutrien Ltd at 11-May-2026.

Wall Street Analyst Michael Tupholme

Analyst best performing recommendations are on NTR (NUTRIEN LTD).
The best stock recommendation documented was for NTR (NUTRIEN LTD) at 2/18/2026. The price target of $80 was fulfilled within 22 days with a profit of $11.38 (16.58%) receiving and performance score of 7.54.

Average potential price target upside

NTR Nutrien Ltd STN Stantec

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Dec-2024

$78

$8.26 (11.84%)

$80

Buy Since 08-Jan-2018

$85

$15.26 (21.88%)

1 months 7 days ago
(18-Sep-2026)

22/29 (75.86%)

$8.5 (11.11%)

449

Buy Since 27-Jul-2026

$78

$8.26 (11.84%)

$81

2 months 14 days ago
(11-Aug-2026)

12/19 (63.16%)

$11.23 (16.82%)

388

Buy Since 16-Jul-2026

$63

$-6.74 (-9.66%)

$96

3 months 9 days ago
(16-Jul-2026)

9/11 (81.82%)

$-3.59 (-5.39%)

326

Hold Since 23-Jan-2024

$75

$5.26 (7.54%)

$68

3 months 11 days ago
(14-Jul-2026)

13/13 (100%)

$6.88 (10.10%)

124

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Tupholme most bullish on?

Potential upside of $13.26 has been obtained for NTR (NUTRIEN LTD)

What Year was the first public recommendation made by Michael Tupholme?

On 2018
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?